Molecular implications of the antiandrogen withdrawal syndrome.
Publication
, Chapter
Moul, JW; Srivastava, S; McLeod, DG
May 1995
Duke Scholars
Publication Date
May 1995
Volume
13
Start / End Page
157 / 163
Related Subject Headings
- Substance Withdrawal Syndrome
- Receptors, Androgen
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Orchiectomy
- Mutation
- Male
- Humans
- Flutamide
- Androgen Antagonists
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W., Srivastava, S., & McLeod, D. G. (1995). Molecular implications of the antiandrogen withdrawal syndrome. (Vol. 13, pp. 157–163).
Moul, J. W., S. Srivastava, and D. G. McLeod. “Molecular implications of the antiandrogen withdrawal syndrome.,” 13:157–63, 1995.
Moul JW, Srivastava S, McLeod DG. Molecular implications of the antiandrogen withdrawal syndrome. In 1995. p. 157–63.
Moul, J. W., et al. Molecular implications of the antiandrogen withdrawal syndrome. Vol. 13, 1995, pp. 157–63.
Moul JW, Srivastava S, McLeod DG. Molecular implications of the antiandrogen withdrawal syndrome. 1995. p. 157–163.
Publication Date
May 1995
Volume
13
Start / End Page
157 / 163
Related Subject Headings
- Substance Withdrawal Syndrome
- Receptors, Androgen
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Orchiectomy
- Mutation
- Male
- Humans
- Flutamide
- Androgen Antagonists